Intco Medical Technology Co., Ltd.

SZSE:300677.SZ

22.44 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013
Revenue 6,918.7246,613.81416,240.09413,836.7152,082.9351,892.541,750.4781,183.107998.022884.713713.279
Cost of Revenue 5,971.0235,745.7176,251.6264,285.311,560.1121,420.5021,314.298893.304734.831726.574607.03
Gross Profit 947.702868.0979,988.4689,551.404522.823472.039436.18289.803263.19158.139106.248
Gross Profit Ratio 0.1370.1310.6150.690.2510.2490.2490.2450.2640.1790.149
Reseach & Development Expenses 283.373252.323365.225293.30167.59562.55956.91438.14828.73424.88220.47
General & Administrative Expenses 153.471130.103285.488132.69834.82931.03625.00622.37534.49412.83150.732
Selling & Marketing Expenses 251.802217.827383.712323.635132.366119.638106.66192.24486.33246.49225.74
SG&A 405.273347.93669.2456.334167.195150.674131.667114.619120.82659.32376.472
Other Expenses 179.395298.311281.988158.66163.62.695-5.5890.738-0.521-1.080.067
Operating Expenses 1,048.659898.5641,316.413908.296298.39276.91232.392186.622178.681107.53878.206
Operating Income 438.99707.1848,688.7258,368.929202.454203.511168.446100.21778.38139.7410.731
Operating Income Ratio 0.0630.1070.5350.6050.0970.1080.0960.0850.0790.0450.015
Total Other Income Expenses Net 3.828-2.77-40.032-22.2910.81911.485-40.931-5.046-10.393-13.27-17.306
Income Before Tax 442.818704.4148,648.6938,346.638203.273206.614162.85798.13574.11637.33110.737
Income Before Tax Ratio 0.0640.1070.5330.6030.0980.1090.0930.0830.0740.0420.015
Income Tax Expense 54.75365.0711,185.2211,342.12725.00627.27517.77311.8739.8965.5820.042
Net Income 382.998629.077,430.0767,007.048178.316179.339145.08486.26364.2231.85410.697
Net Income Ratio 0.0550.0950.4580.5060.0860.0950.0830.0730.0640.0360.015
EPS 0.580.9911.3712.210.340.340.320.220.190.10.037
EPS Diluted 0.580.951111.310.330.340.320.220.190.10.037
EBITDA 1,323.5641,404.3319,098.558,523.608322.56306.596250.3154.759124.8878.45853.781
EBITDA Ratio 0.1910.2120.560.6160.1550.1620.1430.1310.1250.0890.075